Downar eugene (4 Ergebnisse)

Autor
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (4)

  • Neu (4)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

    • Sprache: Englisch

      Verlag: Springer, 2002

      1402001479 / 9781402001475

      Serie: Buch 108 von 253 - Developments in Cardiovascular Medicine

      • Hardcover

      Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 313,15

      EUR 13,17 Versand 
      Versand von Vereinigtes Königreich nach USA

      Anzahl: Mehr als 20 verfügbar

      Zustand: New. In.

    • Sprache: Englisch

      Verlag: Kluwer Academic Publishers, 2002

      1402001479 / 9781402001475

      Serie: Buch 108 von 253 - Developments in Cardiovascular Medicine

      • Hardcover

      Anbieter: Kennys Bookstore, Olney, MD, USAKennys Bookstore

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 319,48

      EUR 9,05 Versand 
      Versand innerhalb von USA

      Anzahl: 15 verfügbar

      Zustand: New. Provides a forum in which the authors present their experience, even if only in its preliminary stages, in the respective field or technology. Editor(s): Liem, L.Bing; Downar, Eugene; Liong Bing Liem (Stanford University Medical Center, California, USA). Series: Developments in Cardiovascular Medicine. Num Pages: 590 pages, biography. BIC Classification: MFG; MJD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 240 x 160 x 37. Weight in Grams: 1096. . 2001. Hardback. . . . . Books ship from the US and Ireland.

    • Sprache: Englisch

      Verlag: Springer, 2012

      9048158826 / 9789048158829

      Serie: Buch 108 von 253 - Developments in Cardiovascular Medicine

      • Softcover

      Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 297,68

      EUR 30,50 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized the technology from a barotraumatic, potentially injurious procedure using high voltage, direct-current (DC) shock to a safe and relatively painless one; catheter ablation procedure now carries a very low risk and is extremely effective for certain types of arrhythmia. Its efficacy rate in curing supraventricular tachycardia involving an accessory pathway or dual atrioventricular nodal pathways has been near perfect and its application for certain types of atrial and ventricular arrhythmia have also been very satisfactory. However, conventional RF ablation has several well known limitations, most notably is its ability to only produce relatively small, point lesions; rendering it effective only for an arrhythmia with a small and/or a superficial target. It was soon recognized that the technology would not likely to have significant utility in arrhythmia with a more widespread target such as atrial fibrillation or those which involve scarred and deep myocardial tissue such as ventricular tachycardia. Indeed, the application of conventional RF technology in these complex but common arrhythmia has yielded unsatisfactory results.

    • Sprache: Englisch

      Verlag: Springer, 2002

      1402001479 / 9781402001475

      Serie: Buch 108 von 253 - Developments in Cardiovascular Medicine

      • Hardcover

      Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 437,44

      EUR 38,02 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized the technology from a barotraumatic, potentially injurious procedure using high voltage, direct-current (DC) shock to a safe and relatively painless one; catheter ablation procedure now carries a very low risk and is extremely effective for certain types of arrhythmia. Its efficacy rate in curing supraventricular tachycardia involving an accessory pathway or dual atrioventricular nodal pathways has been near perfect and its application for certain types of atrial and ventricular arrhythmia have also been very satisfactory. However, conventional RF ablation has several well known limitations, most notably is its ability to only produce relatively small, point lesions; rendering it effective only for an arrhythmia with a small and/or a superficial target. It was soon recognized that the technology would not likely to have significant utility in arrhythmia with a more widespread target such as atrial fibrillation or those which involve scarred and deep myocardial tissue such as ventricular tachycardia. Indeed, the application of conventional RF technology in these complex but common arrhythmia has yielded unsatisfactory results.